scholarly journals Serum Soluble CD163 as a Predictor of Esophageal Varices and Variceal Bleeding in Cirrhotic Patients

2021 ◽  
Vol 83 (1) ◽  
pp. 1629-1637
Author(s):  
Mahmoud Rizk ◽  
Ahmed Mohamed Hussein ◽  
Mohamed Abd Ellatif Afifi ◽  
Amany A. Amer
2017 ◽  
Vol 37 (3) ◽  
pp. 112-118 ◽  
Author(s):  
Rabab Fouad ◽  
Iman Hamza ◽  
Marwa Khairy ◽  
Marwa Elsharkawy ◽  
Amal A. Helmy

2019 ◽  
Vol 54 (3) ◽  
pp. 311-318 ◽  
Author(s):  
Pawel Rogalski ◽  
Magdalena Rogalska-Plonska ◽  
Eugeniusz Wroblewski ◽  
Ines Kostecka-Roslen ◽  
Milena Dabrowska ◽  
...  

2010 ◽  
Vol 9 (1) ◽  
pp. 15-22 ◽  
Author(s):  
Rosa María Pérez-Ayuso ◽  
Sebastián Valderrama ◽  
Manuel Espinoza ◽  
Antonio Rollán ◽  
René Sánchez ◽  
...  

Hepatology ◽  
1997 ◽  
Vol 25 (6) ◽  
pp. 1346-1350 ◽  
Author(s):  
C Lay ◽  
Y Tsai ◽  
C Y Teg ◽  
W S Shyu ◽  
W S Guo ◽  
...  

Author(s):  
Mohamed Yousri Taher ◽  
Abeer El-Hadidi ◽  
Assem  El-Shendidi ◽  
Ahmed Sedky

<b><i>Introduction:</i></b> Activation of hepatic macrophages in liver disease is pathogenically related to portal hypertension (PH). Soluble CD163 (sCD163) is shed in blood by activated macrophages and may predict PH progression noninvasively. This study was designed to investigate the relation of serum sCD163 to the grade and bleeding risk of esophageal varices (EV) and its role for prediction of variceal hemorrhage (VH). <b><i>Methods:</i></b> The study included cirrhotic patients divided into 3 groups: patients who presented with acute upper gastrointestinal bleeding (UGIB) proved to originate from EV on endoscopy, patients without any history of UGIB but who revealed EV on surveillance endoscopy, and patients without endoscopic evidence of varices. Variceal grade and risk signs and bleeding stigmata were noted simultaneously with measurement of serum sCD163 concentration. <b><i>Results:</i></b> Serum sCD163 concentration showed a significant increase in cirrhotic patients compared to healthy subjects (<i>p</i> &#x3c; 0.001) with a stepwise increase among the group without varices, nonbleeder group, and bleeder group sequentially. Serum sCD163 levels correlated positively with the variceal grade and risk signs in both the bleeder and nonbleeder groups (<i>p</i> = 0.002, <i>p</i> &#x3c; 0.001 and <i>p</i> = 0.004, <i>p</i> &#x3c; 0.001, respectively). Serum sCD163 at a cutoff value of 3.6 mg/L performed significantly for prediction of EV presence (AUC = 0.888). Serum sCD163 at a cutoff value &#x3e;4 mg/L significantly predicted large-size and high-risk EV (AUC = 0.910 and AUC = 0.939, respectively) and the index bleed risk (AUC = 0.977). Serum sCD163 at a cutoff value &#x3e;4.05 mg/L modestly discriminated bleeding EV from those that had never bled (AUC = 0.811). <b><i>Conclusions:</i></b> Serum sCD163 levels accurately predicted high-grade and high-risk EV and could help plan for primary prophylaxis. However, it modestly identified VH occurrence, and endoscopy would be required to make a definitive diagnosis.


2018 ◽  
Vol 24 (1) ◽  
pp. 80-92
Author(s):  
Sahar Zaghloul ◽  
Hoda El Hady ◽  
Hussein Hussein ◽  
Islam Hassan

2019 ◽  
pp. 35-40
Author(s):  
Thi Nhung Nguyen ◽  
Trung Nam Phan ◽  
Van Huy Tran

Bacground: Variceal bleeding is a severe complication of portal hypertension due to cirrhosis with high rate of motality, hence, predicting early rebleeding and mortality in cirrhotic patients with acute variceal bleeding is vital in clinical practice. Objectives: To evaluate the prognostic value of the combination of AIMS65 and MELD scores in predicting first 5 days in-hospital rebleeding and mortality in cirrhotic patients with acute variceal bleeding. Materials and Methods: 44 cirrhotic patients with acute variceal bleeding hospitalized at Hue Central Hospital. MELD and AIMS65 scores were calculated within the first 24 hours and monitoring rebleeding and mortality in the first 5 days in these patients. Results: AIMS65, MELD scores can predict first 5 days rebleeding and mortality with AUROC are 0.81, 0.69 and 0.92, 0.95, respectively. Combination of AIMS65 and MELD scores can predict first 5 days in hospital rebleeding with AUROC is 0.84, sensitivity 83.3%, specificity 81.6% (p<0.001) and mortality with AUROC is 0.96, sensitivity 100%, specificity 92.7% (p<0.001). Conclusions: The combination of AIMS65 and MELD scores increased the sensitivity, specificity and prognostic value in predicting first 5 days in-hospital rebleeding and mortality in cirrhotic patients with acute variceal bleeding in compare to each single scores. Key words: AiMS65 score, MELd, acute variceal bleeding


2014 ◽  
Vol 13 (3) ◽  
pp. 364-369 ◽  
Author(s):  
Zuo-Hua Gan ◽  
Chen-Chi Tsai ◽  
Kuo-Chih Tseng ◽  
Chih-Chun Tsai ◽  
Yu-Hsi Hsieh ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document